Blumenthal Urges Pre-Release Review of AI Products, Warning US Could Lose Control Completely
Updated
Updated · CNBC · Sep 16
Blumenthal Urges Pre-Release Review of AI Products, Warning US Could Lose Control Completely
2 articles · Updated · CNBC · Sep 16
Summary
Richard Blumenthal said new AI products should face an "objective review" before release, arguing the technology is nearing a point where developers and regulators could lose control.
The Connecticut senator said any rules must be narrowly targeted and expert-led—likening the approach to FDA drug oversight—because Congress lacks deep AI expertise.
Blumenthal framed the push as a balance between safety and competitiveness, saying the U.S. must preserve its AI edge even as it adds scrutiny.
The call lands amid widening splits in Washington and Silicon Valley: Sam Altman and Dario Amodei have warned about advanced-model risks, while President Donald Trump has dismissed those fears and prioritized beating China.